Frontier
Copyright ©The Author(s) 2022.
World J Diabetes. May 15, 2022; 13(5): 387-407
Published online May 15, 2022. doi: 10.4239/wjd.v13.i5.387
Figure 4
Figure 4 Effect of cannabinoid receptors on adenosine monophosphate activated protein kinase/mammalian target of rapamycin complex 1/NLR family pyrin domain containing 3 signaling. Cannabinoids enhance the phosphorylation of adenosine monophosphate activated protein kinase (AMPK), which reduces the stimulatory effect of mammalian target of rapamycin complex 1 (mTORC1) on inflammasome assembly. Depressed activation of NLR family pyrin domain containing 3 (NLRP3) will diminish the activation of procaspase-1 leading to a decrease in interleukin-1β (IL-1β) and IL-18 production. Additionally, the inhibitory effect of phosphorylated AMPK on mTORC1 will enhance autophagy. AMPK: Adenosine monophosphate activated protein kinase; mTORC1: Mammalian target of rapamycin complex 1; NLRP3: NLR family pyrin domain containing 3; IL: Interleukin.